Idarubicin - Induced apoptosis in HL-60 cells: relationship between apoptosis and time dependence of apoptosis on Idarubicin dose
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60162694%3AG16__%2F00%3A00000377" target="_blank" >RIV/60162694:G16__/00:00000377 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Idarubicin - Induced apoptosis in HL-60 cells: relationship between apoptosis and time dependence of apoptosis on Idarubicin dose
Popis výsledku v původním jazyce
Apoptosis in HL-60 human leukaemia cells treated in vitro with idarubicin (4 hours incubation) was quantified using morphologic changes in the nuclear and cytoplasmic structures in Diff-Quik stained cytospin preparations, flow cytometric measurement of sub-diploid DNA content (sub-G1 cells) and increase of staining with APO 2.7 antibody in nonpermeabilised cells. After treatment by high (20-100 nmol) doses of idarubicin HL-60 cells were found to die earlier, primarily by apoptosis, regardless of the cell-cycle phase, in which they were affected. We have observed that after 6 hours of incubation with small (10 nmol/l) idarubicin dose most of the live cells were in S phase of cell cycle (62%), after 24 hour most of them moved to G2 phase (61%). Increaseof apoptotic cells (20%) was observed as late as 48 and 72 hours after 4 hours incubation with idarubicin. After 72 hours 50% of cells were necrotic (Trypan blue staining).
Název v anglickém jazyce
Idarubicin - Induced apoptosis in HL-60 cells: relationship between apoptosis and time dependence of apoptosis on Idarubicin dose
Popis výsledku anglicky
Apoptosis in HL-60 human leukaemia cells treated in vitro with idarubicin (4 hours incubation) was quantified using morphologic changes in the nuclear and cytoplasmic structures in Diff-Quik stained cytospin preparations, flow cytometric measurement of sub-diploid DNA content (sub-G1 cells) and increase of staining with APO 2.7 antibody in nonpermeabilised cells. After treatment by high (20-100 nmol) doses of idarubicin HL-60 cells were found to die earlier, primarily by apoptosis, regardless of the cell-cycle phase, in which they were affected. We have observed that after 6 hours of incubation with small (10 nmol/l) idarubicin dose most of the live cells were in S phase of cell cycle (62%), after 24 hour most of them moved to G2 phase (61%). Increaseof apoptotic cells (20%) was observed as late as 48 and 72 hours after 4 hours incubation with idarubicin. After 72 hours 50% of cells were necrotic (Trypan blue staining).
Klasifikace
Druh
C - Kapitola v odborné knize
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
Z - Vyzkumny zamer (s odkazem do CEZ)
Ostatní
Rok uplatnění
2000
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název knihy nebo sborníku
Cells II
ISBN
80-7232-120-X
Počet stran výsledku
1
Strana od-do
—
Počet stran knihy
—
Název nakladatele
Kopp
Místo vydání
České Budějovice
Kód UT WoS kapitoly
—